Ken Griffin Avanos Medical, Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Avanos Medical, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 800 shares of AVNS stock, worth $16,344. This represents 0.0% of its overall portfolio holdings.

Number of Shares

800

Previous 3,900 79.49%

Holding current value

$16,344

Previous $77,000 80.52%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$17.85 - $20.42 $263,965 - $301,970	-14,788 Reduced 6.37%	217,425 $4.33 Million
Q1 2024 May 15, 2024	SELL	$17.97 - $22.68 $412,806 - $521,004	-22,972 Reduced 9.0%	232,213 $4.62 Million
Q4 2023 Feb 14, 2024	BUY	$17.64 - $22.99 $1.46 Million - $1.9 Million	82,726 Added 47.97%	255,185 $5.72 Million
Q3 2023 Nov 14, 2023	SELL	$19.93 - $26.31 $3.57 Million - $4.72 Million	-179,237 Reduced 50.96%	172,459 $3.49 Million
Q2 2023 Aug 14, 2023	BUY	$22.53 - $30.98 $7.28 Million - $10 Million	323,030 Added 1126.88%	351,696 $8.99 Million
Q1 2023 May 15, 2023	SELL	$26.92 - $31.75 $4.25 Million - $5.01 Million	-157,846 Reduced 84.63%	28,666 $852,000
Q4 2022 Feb 14, 2023	BUY	$19.88 - $27.37 $446,206 - $614,319	22,445 Added 13.68%	186,512 $5.05 Million
Q3 2022 Nov 14, 2022	BUY	$21.56 - $29.59 $1.49 Million - $2.04 Million	68,933 Added 72.46%	164,067 $3.57 Million
Q2 2022 Aug 15, 2022	SELL	$24.87 - $34.68 $205,078 - $285,971	-8,246 Reduced 7.98%	95,134 $2.6 Million
Q1 2022 May 16, 2022	BUY	$28.87 - $35.77 $1.1 Million - $1.37 Million	38,251 Added 58.73%	103,380 $3.46 Million
Q4 2021 Feb 14, 2022	BUY	$29.25 - $36.02 $832,162 - $1.02 Million	28,450 Added 77.56%	65,129 $2.26 Million
Q3 2021 Nov 15, 2021	BUY	$31.2 - $38.5 $577,044 - $712,057	18,495 Added 101.71%	36,679 $1.14 Million
Q2 2021 Aug 16, 2021	SELL	$36.37 - $45.72 $2.77 Million - $3.49 Million	-76,247 Reduced 80.74%	18,184 $661,000
Q1 2021 May 17, 2021	BUY	$43.5 - $53.4 $1.8 Million - $2.21 Million	41,401 Added 78.07%	94,431 $4.13 Million
Q3 2020 Nov 16, 2020	SELL	$28.67 - $34.32 $1.54 Million - $1.84 Million	-53,713 Reduced 50.32%	53,030 $1.76 Million
Q2 2020 Aug 14, 2020	BUY	$23.48 - $33.86 $621,069 - $895,630	26,451 Added 32.94%	106,743 $3.14 Million
Q1 2020 May 15, 2020	SELL	$20.64 - $34.41 $152,199 - $253,739	-7,374 Reduced 8.41%	80,292 $2.16 Million
Q3 2019 Nov 14, 2019	SELL	$32.06 - $44.0 $569,289 - $781,308	-17,757 Reduced 16.84%	87,666 $3.28 Million
Q2 2019 Aug 14, 2019	BUY	$37.68 - $46.52 $3.43 Million - $4.24 Million	91,075 Added 634.76%	105,423 $4.6 Million
Q1 2019 May 15, 2019	BUY	$39.84 - $51.04 $379,954 - $486,768	9,537 Added 198.23%	14,348 $0
Q4 2018 Feb 14, 2019	SELL	$41.16 - $66.67 $313,145 - $507,225	-7,608 Reduced 61.26%	4,811 $215,000
Q3 2018 Nov 13, 2018	BUY	$55.13 - $72.65 $684,659 - $902,240	12,419 New	12,419 $0

Others Institutions Holding AVNS

# of Institutions

272

Shares Held

41.8M

Call Options Held

800

Put Options Held

9.2K

View Full List

About AVANOS MEDICAL, INC.

Ticker AVNS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 46,487,000
Market Cap $950M
Description
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, ...

More about AVNS

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account